FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3165208259> ?p ?o ?g. }

• W3165208259 endingPage "802" @default.
• W3165208259 startingPage "802" @default.
• W3165208259 abstract "The urgent need for novel and effective drugs against the SARS-CoV-2 coronavirus pandemic has stimulated research worldwide. The Papain-like protease (PLpro), which is essential for viral replication, shares a similar active site structural architecture to other cysteine proteases. Here, we have used representatives of the Ovarian Tumor Domain deubiquitinase family OTUB1 and OTUB2 along with the PLpro of SARS-CoV-2 to validate and rationalize the binding of inhibitors from previous SARS-CoV candidate compounds. By forming a new chemical bond with the cysteine residue of the catalytic triad, covalent inhibitors irreversibly suppress the protein’s activity. Modeling covalent inhibitor binding requires detailed knowledge about the compounds’ reactivities and binding. Molecular Dynamics refinement simulations of top poses reveal detailed ligand-protein interactions and show their stability over time. The recently discovered selective OTUB2 covalent inhibitors were used to establish and validate the computational protocol. Structural parameters and ligand dynamics are in excellent agreement with the ligand-bound OTUB2 crystal structures. For SARS-CoV-2 PLpro, recent covalent peptidomimetic inhibitors were simulated and reveal that the ligand-protein interaction is very dynamic. The covalent and non-covalent docking plus subsequent MD refinement of known SARS-CoV inhibitors into DUBs and the SARS-CoV-2 PLpro point out a possible approach to target the PLpro cysteine protease from SARS-CoV-2. The results show that such an approach gives insight into ligand-protein interactions, their dynamic character, and indicates a path for selective ligand design." @default.
• W3165208259 created "2021-06-07" @default.
• W3165208259 creator A5075574726 @default.
• W3165208259 creator A5083460661 @default.
• W3165208259 date "2021-05-28" @default.
• W3165208259 modified "2023-10-18" @default.
• W3165208259 title "Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases" @default.
• W3165208259 cites W1816800410 @default.
• W3165208259 cites W1967407510 @default.
• W3165208259 cites W1970232220 @default.
• W3165208259 cites W1972356153 @default.
• W3165208259 cites W1985588649 @default.
• W3165208259 cites W1990724722 @default.
• W3165208259 cites W1995770177 @default.
• W3165208259 cites W1995850373 @default.
• W3165208259 cites W2005263607 @default.
• W3165208259 cites W2009423060 @default.
• W3165208259 cites W2020896146 @default.
• W3165208259 cites W2027423337 @default.
• W3165208259 cites W2029927025 @default.
• W3165208259 cites W2031168104 @default.
• W3165208259 cites W2034368227 @default.
• W3165208259 cites W2043767415 @default.
• W3165208259 cites W2047717104 @default.
• W3165208259 cites W2056022472 @default.
• W3165208259 cites W2081327421 @default.
• W3165208259 cites W2091869585 @default.
• W3165208259 cites W2102377211 @default.
• W3165208259 cites W2115985833 @default.
• W3165208259 cites W2117434067 @default.
• W3165208259 cites W2610740470 @default.
• W3165208259 cites W2949252818 @default.
• W3165208259 cites W3008142620 @default.
• W3165208259 cites W3009436665 @default.
• W3165208259 cites W3011701533 @default.
• W3165208259 cites W3013855790 @default.
• W3165208259 cites W3014590847 @default.
• W3165208259 cites W3014852814 @default.
• W3165208259 cites W3021411957 @default.
• W3165208259 cites W3022472330 @default.
• W3165208259 cites W3046218096 @default.
• W3165208259 cites W3080855264 @default.
• W3165208259 cites W3092736134 @default.
• W3165208259 cites W3113182646 @default.
• W3165208259 cites W3120274460 @default.
• W3165208259 cites W3161288330 @default.
• W3165208259 doi "https://doi.org/10.3390/biom11060802" @default.
• W3165208259 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8227062" @default.
• W3165208259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34071582" @default.
• W3165208259 hasPublicationYear "2021" @default.
• W3165208259 type Work @default.
• W3165208259 sameAs 3165208259 @default.
• W3165208259 citedByCount "4" @default.
• W3165208259 countsByYear W31652082592022 @default.
• W3165208259 countsByYear W31652082592023 @default.
• W3165208259 crossrefType "journal-article" @default.
• W3165208259 hasAuthorship W3165208259A5075574726 @default.
• W3165208259 hasAuthorship W3165208259A5083460661 @default.
• W3165208259 hasBestOaLocation W31652082591 @default.
• W3165208259 hasConcept C102658986 @default.
• W3165208259 hasConcept C104317684 @default.
• W3165208259 hasConcept C116569031 @default.
• W3165208259 hasConcept C124790011 @default.
• W3165208259 hasConcept C159110408 @default.
• W3165208259 hasConcept C170493617 @default.
• W3165208259 hasConcept C178790620 @default.
• W3165208259 hasConcept C180577832 @default.
• W3165208259 hasConcept C181199279 @default.
• W3165208259 hasConcept C182220744 @default.
• W3165208259 hasConcept C185592680 @default.
• W3165208259 hasConcept C25602115 @default.
• W3165208259 hasConcept C2776714187 @default.
• W3165208259 hasConcept C2777283782 @default.
• W3165208259 hasConcept C2779201268 @default.
• W3165208259 hasConcept C2779281246 @default.
• W3165208259 hasConcept C2779832904 @default.
• W3165208259 hasConcept C41685203 @default.
• W3165208259 hasConcept C55493867 @default.
• W3165208259 hasConcept C71240020 @default.
• W3165208259 hasConcept C71924100 @default.
• W3165208259 hasConceptScore W3165208259C102658986 @default.
• W3165208259 hasConceptScore W3165208259C104317684 @default.
• W3165208259 hasConceptScore W3165208259C116569031 @default.
• W3165208259 hasConceptScore W3165208259C124790011 @default.
• W3165208259 hasConceptScore W3165208259C159110408 @default.
• W3165208259 hasConceptScore W3165208259C170493617 @default.
• W3165208259 hasConceptScore W3165208259C178790620 @default.
• W3165208259 hasConceptScore W3165208259C180577832 @default.
• W3165208259 hasConceptScore W3165208259C181199279 @default.
• W3165208259 hasConceptScore W3165208259C182220744 @default.
• W3165208259 hasConceptScore W3165208259C185592680 @default.
• W3165208259 hasConceptScore W3165208259C25602115 @default.
• W3165208259 hasConceptScore W3165208259C2776714187 @default.
• W3165208259 hasConceptScore W3165208259C2777283782 @default.
• W3165208259 hasConceptScore W3165208259C2779201268 @default.
• W3165208259 hasConceptScore W3165208259C2779281246 @default.
• W3165208259 hasConceptScore W3165208259C2779832904 @default.
• W3165208259 hasConceptScore W3165208259C41685203 @default.

• next